Real-time enrollment status for this masld - metabolic dysfunction-associated steatotic liver disease clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:25 PM UTC
| NCT Number | NCT07097506 |
| Recruiting Status | Recruiting |
| Condition | MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Washington University School of Medicine |
| Last Updated on CT.gov | July 15, 2026 (Jul 15, 2026) |
As of October 12, 2026: Clinical trial NCT07097506 is currently recruiting participants. This phase2 study for masld - metabolic dysfunction-associated steatotic liver disease is actively seeking new participants at 1 location across the United States. The study is sponsored by Washington University School of Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07097506 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07097506 was last updated Jul 15, 2026 (July 15, 2026). HelloStudys verifies this status automatically.